Name
Alnylam Pharmaceuticals, Inc.
Company Description
Alnylam has led the translation of RNA interference into a new class of approved and investigational medicines for rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS)/ocular diseases. Learn more: www.alnylam.com.
Website
Product Categories (5)
Biotechnology Pharmaceuticals
Address
300 3rd St
Cambridge, MA 02142-1103
United States
Cambridge, MA 02142-1103
United States
Instagram
Twitter